Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest ...

A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...

Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

If you are wondering whether CRISPR Therapeutics at about US$53.84 is still priced attractively or already baking in a lot of expectations, you are asking the right question. The stock has seen a ...

Which genes are required for turning embryonic stem cells into brain cells, and what happens when this process goes wrong? In ...